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In 2009, an editorial by Putman focused on the dramatic
increase in the use of proton pump inhibitors (PPIs) in
infants [1]. Considering the increasing evidence that
PPIs offer little benefit for most of the symptoms for
which they are prescribed, Putman strongly highlighted
the need for a serious effort to curtail their empiric use.
The editorial was linked to a study by Orenstein et al,
which detected no difference in efficacy between lanso-
prazole and placebo for symptoms attributed to gastroe-
sophageal reflux disease (GERD) in infants [2]. A very
recent review on the effects of PPIs on irritability and
crying in infants confirmed the conclusion that these
drugs do not offer relief from these symptoms for which
they are commonly prescribed [3]. After all, it has
recently been pointed out that volume rather than acid
is often the key promoter of reflux-associated symptoms
in infants. Distension-induced increase in gastric wall
tension has been associated with high rates of transient
lower esophageal sphincter relaxations and is considered
one of the main mechanisms contributing to postpran-
dial GER [4]. Despite all these evidences on PPIs unef-
fectiveness for many of the symptoms for which they
are commonly prescribed, the rate of their prescriptions
have exponentially increased over the last years. The
latest combined NASPGHAN/ESPGHAN guidelines
already in 2009 highlighted the need to distinguish phy-
siologic GER events from GERD, limiting for the latter
the use of PPIs [5]. However, a 2012 European survey
carried out by our study group showed that only 1.8%
of pediatricians reported a complete adherence to the
guideline recommendations in their clinical practice.
The most relevant violation of the guideline recommen-
dations concerned the prescription of unnecessary acid
suppressive medications [6] (Figure 1). In order to
inquire into the reasons why pediatricians did not follow
the guideline recommendations, we performed another
trial with the same pediatricians undergoing specific
training on the guidelines being supervised in their clini-
cal practice. As a result, trained pediatricians showed a
significantly higher compliance with the international
guidelines and infants with unexplained crying and dis-
tressed behaviour or with uncomplicated recurrent
regurgitation and vomiting who were unproperly pre-
scribed PPIs decreased dramatically [7]. Besides these
data on PPI overuse, recent studies highlighted the
occurrence of several adverse effects related to their
assumption, such as a higher risk of bronchoalveolar
lavage culture positivity and gastric bacterial overgrowth,
food allergy, Clostridium difficile infection, gastric polyps
and nodules [8-12].
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Figure 1 Rates of pediatricians over-prescribing PPIs in the different
European countries
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